Edwards Lifesciences Corporation (EW) DCF Valuation
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Edwards Lifesciences Corporation (EW) Bundle
Simplify Edwards Lifesciences Corporation (EW) valuation with this customizable DCF Calculator! Featuring real Edwards Lifesciences Corporation (EW) financials and adjustable forecast inputs, you can test scenarios and uncover Edwards Lifesciences Corporation (EW) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,348.0 | 4,386.3 | 5,232.5 | 5,382.4 | 6,004.8 | 6,524.2 | 7,088.6 | 7,701.8 | 8,368.0 | 9,091.9 |
| Revenue Growth, % | 0 | 0.88086 | 19.29 | 2.86 | 11.56 | 8.65 | 8.65 | 8.65 | 8.65 | 8.65 |
| EBITDA | 1,308.4 | 1,074.3 | 1,890.1 | 1,960.4 | 1,767.6 | 2,042.9 | 2,219.7 | 2,411.7 | 2,620.3 | 2,846.9 |
| EBITDA, % | 30.09 | 24.49 | 36.12 | 36.42 | 29.44 | 31.31 | 31.31 | 31.31 | 31.31 | 31.31 |
| Depreciation | 114.6 | 135.4 | 163.3 | 166.8 | 144.9 | 187.3 | 203.5 | 221.1 | 240.3 | 261.0 |
| Depreciation, % | 2.64 | 3.09 | 3.12 | 3.1 | 2.41 | 2.87 | 2.87 | 2.87 | 2.87 | 2.87 |
| EBIT | 1,193.8 | 938.9 | 1,726.8 | 1,793.6 | 1,622.7 | 1,855.6 | 2,016.1 | 2,190.5 | 2,380.0 | 2,585.9 |
| EBIT, % | 27.46 | 21.41 | 33 | 33.32 | 27.02 | 28.44 | 28.44 | 28.44 | 28.44 | 28.44 |
| Total Cash | 1,516.9 | 1,402.6 | 1,466.8 | 1,215.3 | 1,644.5 | 1,890.2 | 2,053.7 | 2,231.4 | 2,424.4 | 2,634.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 599.1 | 602.8 | 664.9 | 699.1 | 836.9 | 876.3 | 952.1 | 1,034.4 | 1,123.9 | 1,221.1 |
| Account Receivables, % | 13.78 | 13.74 | 12.71 | 12.99 | 13.94 | 13.43 | 13.43 | 13.43 | 13.43 | 13.43 |
| Inventories | 640.9 | 802.3 | 726.7 | 875.5 | 1,168.2 | 1,078.3 | 1,171.6 | 1,272.9 | 1,383.1 | 1,502.7 |
| Inventories, % | 14.74 | 18.29 | 13.89 | 16.27 | 19.45 | 16.53 | 16.53 | 16.53 | 16.53 | 16.53 |
| Accounts Payable | 180.4 | 196.5 | 204.5 | 201.9 | 201.4 | 256.3 | 278.5 | 302.6 | 328.7 | 357.2 |
| Accounts Payable, % | 4.15 | 4.48 | 3.91 | 3.75 | 3.35 | 3.93 | 3.93 | 3.93 | 3.93 | 3.93 |
| Capital Expenditure | -278.4 | -407.3 | -329.8 | -264.8 | -266.3 | -409.0 | -444.4 | -482.8 | -524.6 | -570.0 |
| Capital Expenditure, % | -6.4 | -9.29 | -6.3 | -4.92 | -4.43 | -6.27 | -6.27 | -6.27 | -6.27 | -6.27 |
| Tax Rate, % | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 |
| EBITAT | 1,071.4 | 843.3 | 1,525.0 | 1,544.5 | 1,424.0 | 1,639.4 | 1,781.2 | 1,935.3 | 2,102.7 | 2,284.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -152.0 | 422.4 | 1,380.0 | 1,260.9 | 871.6 | 1,523.1 | 1,393.5 | 1,514.0 | 1,645.0 | 1,787.3 |
| WACC, % | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 5,962.0 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 1,859 | |||||||||
| Terminal Value | 32,897 | |||||||||
| Present Terminal Value | 20,754 | |||||||||
| Enterprise Value | 26,716 | |||||||||
| Net Debt | -449 | |||||||||
| Equity Value | 27,165 | |||||||||
| Diluted Shares Outstanding, MM | 609 | |||||||||
| Equity Value Per Share | 44.58 |
What You Will Get
- Real EW Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are updated automatically.
- Scenario Analysis: Evaluate multiple scenarios to assess Edwards Lifesciences' future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- 🔍 Real-Life EW Financials: Pre-filled historical and projected data for Edwards Lifesciences Corporation (EW).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Edwards Lifesciences’ intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Edwards Lifesciences’ valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download: Get the pre-built Excel file featuring Edwards Lifesciences Corporation's (EW) financial data.
- Customize: Tailor your forecasts, including revenue growth, EBITDA %, and WACC.
- Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various projections and instantly compare the results.
- Make Decisions: Leverage the valuation findings to inform your investment strategy.
Why Choose Edwards Lifesciences Corporation (EW)?
- Innovative Solutions: Leading the way in heart valve therapies and hemodynamic monitoring.
- Commitment to Quality: High standards in manufacturing ensure reliable medical devices.
- Patient-Centric Approach: Focused on improving patient outcomes through advanced technology.
- Global Reach: Operates in numerous countries, making a significant impact worldwide.
- Endorsed by Professionals: Trusted by healthcare providers for their expertise and reliability.
Who Should Use This Product?
- Investors: Accurately assess Edwards Lifesciences Corporation's (EW) fair value before making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to Edwards Lifesciences Corporation (EW).
- Consultants: Efficiently modify the template for valuation reports tailored to clients focused on Edwards Lifesciences Corporation (EW).
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading healthcare companies, including Edwards Lifesciences Corporation (EW).
- Educators: Implement it as a teaching resource to illustrate valuation methodologies relevant to Edwards Lifesciences Corporation (EW).
What the Template Contains
- Pre-Filled DCF Model: Edwards Lifesciences Corporation’s (EW) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital specific to (EW).
- Financial Ratios: Evaluate (EW)’s profitability, leverage, and efficiency metrics.
- Editable Inputs: Modify assumptions such as growth, margins, and CAPEX to tailor your scenarios for (EW).
- Financial Statements: Annual and quarterly reports for (EW) to support comprehensive analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results for (EW).